{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T19:09:19Z","timestamp":1767899359535,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Science and Education Cultivation Fund of the National Cancer Regional Medical Center of Shanxi Provincial Cancer Hospital, China","award":["SD2023004"],"award-info":[{"award-number":["SD2023004"]}]},{"name":"Shanxi Special Projects of the Central Government Guiding Loca Science and Technology Development of China","award":["YDZJSX2024B012"],"award-info":[{"award-number":["YDZJSX2024B012"]}]},{"name":"The Shanxi Provincial Natural Science Foundation of China","award":["202403021212228"],"award-info":[{"award-number":["202403021212228"]}]},{"name":"The Science and Education Cultivation Fund of the National Cancer and Regional Medical Center of Shanxi Provincial Cancer Hospital","award":["QH2023045"],"award-info":[{"award-number":["QH2023045"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-30601-5","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T19:46:50Z","timestamp":1764445610000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MiR-106b-5p promotes gastric cancer progression by directly targeting the tumor suppressor RBL2"],"prefix":"10.1038","volume":"16","author":[{"given":"Chen","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tonghan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqing","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanhu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,29]]},"reference":[{"key":"30601_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"30601_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jncc.2024.01.006","volume":"4","author":"B Han","year":"2024","unstructured":"Han, B. et al. Cancer incidence and mortality in China, 2022. J. Natl. Cancer Cent. 4, 47\u201353. https:\/\/doi.org\/10.1016\/j.jncc.2024.01.006 (2024).","journal-title":"J. Natl. Cancer Cent."},{"key":"30601_CR3","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3760\/cma.j.cn112152-20220517-00348","volume":"44","author":"J He","year":"2022","unstructured":"He, J. et al. China guideline for the screening, early detection and early treatment of esophageal cancer (2022, Beijing). Zhonghua Zhong Liu Za Zhi. 44, 491\u2013522. https:\/\/doi.org\/10.3760\/cma.j.cn112152-20220517-00348 (2022).","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"30601_CR4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.32592\/ARI.2025.80.1.217","volume":"80","author":"T Eslammanesh","year":"2025","unstructured":"Eslammanesh, T. et al. Mechanisms of MiRNAs (MicroRNAs) and their expression in gastric cancer. Arch. Razi Inst. 80, 217\u2013224. https:\/\/doi.org\/10.32592\/ARI.2025.80.1.217 (2025).","journal-title":"Arch. Razi Inst."},{"key":"30601_CR5","doi-asserted-by":"publisher","first-page":"623","DOI":"10.7150\/ijbs.55020","volume":"17","author":"W Chen","year":"2021","unstructured":"Chen, W. et al. MEF2A-mediated LncRNA HCP5 inhibits gastric cancer progression via MiR-106b-5p\/p21 axis. Int. J. Biol. Sci. 17, 623\u2013634. https:\/\/doi.org\/10.7150\/ijbs.55020 (2021).","journal-title":"Int. J. Biol. Sci."},{"key":"30601_CR6","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.18632\/oncotarget.2926","volume":"6","author":"W Xiang","year":"2015","unstructured":"Xiang, W. et al. miR-106b-5p targets tumor suppressor gene SETD2 to inactive its function in clear cell renal cell carcinoma. Oncotarget 6, 4066\u20134079. https:\/\/doi.org\/10.18632\/oncotarget.2926 (2015).","journal-title":"Oncotarget"},{"key":"30601_CR7","doi-asserted-by":"publisher","first-page":"606","DOI":"10.33594\/000000043","volume":"52","author":"Z Zhu","year":"2019","unstructured":"Zhu, Z. et al. miR-106b promotes metastasis of early gastric cancer by targeting ALEX1 in vitro and in vivo. Cell. Physiol. Biochem. 52, 606\u2013616. https:\/\/doi.org\/10.33594\/000000043 (2019).","journal-title":"Cell. Physiol. Biochem."},{"key":"30601_CR8","doi-asserted-by":"publisher","first-page":"278","DOI":"10.18632\/oncoscience.467","volume":"5","author":"E Ventura","year":"2018","unstructured":"Ventura, E., Pentimalli, F. & Giordano, A. RBL2\/p130: a direct AKT substrate and mediator of AKT inhibition-induced apoptosis. Oncoscience 5, 278\u2013280. https:\/\/doi.org\/10.18632\/oncoscience.467 (2018).","journal-title":"Oncoscience"},{"key":"30601_CR9","doi-asserted-by":"publisher","first-page":"4813","DOI":"10.1038\/onc.2013.428","volume":"33","author":"F Liu","year":"2014","unstructured":"Liu, F. et al. MicroRNA-106b-5p boosts glioma tumorigensis by targeting multiple tumor suppressor genes. Oncogene 33, 4813\u20134822. https:\/\/doi.org\/10.1038\/onc.2013.428 (2014).","journal-title":"Oncogene"},{"key":"30601_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4137\/tog.s29652","volume":"7","author":"A Arora","year":"2015","unstructured":"Arora, A. et al. Interplay between metabolism and oncogenic process: role of MicroRNAs. Transl Oncogenomics. 7, 11\u201327. https:\/\/doi.org\/10.4137\/tog.s29652 (2015).","journal-title":"Transl Oncogenomics"},{"key":"30601_CR11","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1159\/000485650","volume":"44","author":"K Wei","year":"2017","unstructured":"Wei, K. et al. MiR-106b-5p promotes proliferation and inhibits apoptosis by regulating BTG3 in non-small cell lung cancer. Cell. Physiol. Biochem. 44, 1545\u20131558. https:\/\/doi.org\/10.1159\/000485650 (2017).","journal-title":"Cell. Physiol. Biochem."},{"key":"30601_CR12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12943-021-01361-3","volume":"20","author":"ZR Dong","year":"2021","unstructured":"Dong, Z. R. et al. CircMEMO1 modulates the promoter methylation and expression of TCF21 to regulate hepatocellular carcinoma progression and Sorafenib treatment sensitivity. Mol. Cancer. 20, 75. https:\/\/doi.org\/10.1186\/s12943-021-01361-3 (2021).","journal-title":"Mol. Cancer"},{"key":"30601_CR13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s43032-021-00788-9","volume":"29","author":"H Sun","year":"2022","unstructured":"Sun, H. & Chen, X. MiR-106b-5p promotes malignant behaviors of cervical squamous cell carcinoma cells by targeting TIMP2. Reprod. Sci. 29, 203\u2013211. https:\/\/doi.org\/10.1007\/s43032-021-00788-9 (2022).","journal-title":"Reprod. Sci."},{"key":"30601_CR14","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41419-017-0181-6","volume":"9","author":"X Dong","year":"2018","unstructured":"Dong, X., Hu, X., Chen, J., Hu, D. & Chen, L. F. BRD4 regulates cellular senescence in gastric cancer cells via E2F\/miR-106b\/p21 axis. Cell. Death Dis. 9, 203. https:\/\/doi.org\/10.1038\/s41419-017-0181-6 (2018).","journal-title":"Cell. Death Dis."},{"key":"30601_CR15","doi-asserted-by":"publisher","first-page":"4629","DOI":"10.1073\/pnas.93.10.4629","volume":"93","author":"A Baldi","year":"1996","unstructured":"Baldi, A., Boccia, V., Claudio, P. P., De Luca, A. & Giordano, A. Genomic structure of the human retinoblastoma-related Rb2\/p130 gene. Proc. Natl. Acad. Sci. U S A. 93, 4629\u20134632. https:\/\/doi.org\/10.1073\/pnas.93.10.4629 (1996).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"30601_CR16","first-page":"2003","volume":"56","author":"PP Claudio","year":"1996","unstructured":"Claudio, P. P. et al. Functional analysis of pRb2\/p130 interaction with cyclins. Cancer Res. 56, 2003\u20132008 (1996).","journal-title":"Cancer Res."},{"key":"30601_CR17","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1101\/gad.12.15.2245","volume":"12","author":"N Dyson","year":"1998","unstructured":"Dyson, N. The regulation of E2F by pRB-family proteins. Genes Dev. 12, 2245\u20132262. https:\/\/doi.org\/10.1101\/gad.12.15.2245 (1998).","journal-title":"Genes Dev."},{"key":"30601_CR18","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/s41598-022-05013-4","volume":"12","author":"L Duan","year":"2022","unstructured":"Duan, L., Perez, R. E., Calhoun, S. & Maki, C. G. RBL2\/DREAM-mediated repression of the Aurora kinase A\/B pathway determines therapy responsiveness and outcome in p53 WT NSCLC. Sci. Rep. 12, 1049. https:\/\/doi.org\/10.1038\/s41598-022-05013-4 (2022).","journal-title":"Sci. Rep."},{"key":"30601_CR19","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13046-015-0255-1","volume":"34","author":"AM Mileo","year":"2015","unstructured":"Mileo, A. M. et al. Hepatitis C virus core protein modulates pRb2\/p130 expression in human hepatocellular carcinoma cell lines through promoter methylation. J. Exp. Clin. Cancer Res. 34, 140. https:\/\/doi.org\/10.1186\/s13046-015-0255-1 (2015).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"30601_CR20","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1074\/jbc.m109.043380","volume":"285","author":"CA Reed","year":"2010","unstructured":"Reed, C. A., Mayhew, C. N., McClendon, A. K. & Knudsen, E. S. Unique impact of RB loss on hepatic proliferation: tumorigenic stresses uncover distinct pathways of cell cycle control. J. Biol. Chem. 285, 1089\u20131096. https:\/\/doi.org\/10.1074\/jbc.m109.043380 (2010).","journal-title":"J. Biol. Chem."},{"key":"30601_CR21","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.3892\/etm.2020.8574","volume":"19","author":"C He","year":"2020","unstructured":"He, C. et al. miR-106b-5p promotes cell proliferation and cell cycle progression by directly targeting CDKN1A in osteosarcoma. Exp. Ther. Med. 19, 3203\u20133210. https:\/\/doi.org\/10.3892\/etm.2020.8574 (2020).","journal-title":"Exp. Ther. Med."},{"key":"30601_CR22","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.2147\/ott.s172887","volume":"11","author":"S Ni","year":"2018","unstructured":"Ni, S. et al. miR-106b-5p inhibits the invasion and metastasis of colorectal cancer by targeting CTSA. Onco Targets Ther. 11, 3835\u20133845. https:\/\/doi.org\/10.2147\/ott.s172887 (2018).","journal-title":"Onco Targets Ther."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30601-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30601-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30601-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T14:25:39Z","timestamp":1767882339000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30601-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,29]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["30601"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-30601-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,29]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Written informed consent was obtained from all participants. The studies involving humans were approved by Ethics Committee of Shanxi Province Cancer Hospital, Chinese Academy of Medical Sciences (Shanxi Cancer Hospital) (ethics number: KY2025013). The studies were conducted in accordance with the local legislation and institutional requirements, and all methods are reported in accordance with ARRIVE guidelines. The animal study was approved by Animal Experiment Ethics Review Committee of Shanxi Cancer Hospital (ethics number: G2RWLL2025038). The study was conducted in accordance with the local legislation and institutional requirements. We confirmed that all human tissues were collected prior to chemotherapy.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"985"}}